Projects per year
Personal profile
Courses
Instrumentation Analysis
Instrumentation Analysis Labortory Exercise
Special Topics in Pharmacological Therapeutics
Introduction to Experimental and Biochemical Pharmacology
Instrumentation Analysis Labortory Exercise
Special Topics in Pharmacological Therapeutics
Introduction to Experimental and Biochemical Pharmacology
Education
B.S., Kaohsiung Medical College,Taiwan
1982.0-1986.0
Ph.D., National Taiwan University,Taiwan
1992.0-1997.0
M.S., National Taiwan University,Taiwan
1989.0-1991.0
1982.0-1986.0
Ph.D., National Taiwan University,Taiwan
1992.0-1997.0
M.S., National Taiwan University,Taiwan
1989.0-1991.0
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Keywords
- Basic Medicinal Research
- Cardiac Disease Models
- Cardiovascular Electrophysiology
- Cardiovascular Pharmacology
- Ion Channel Pharmacology
- New Drug Discovery
- Pharmacology
Laboratory
- Cardiovascular Electrophysiology and Pharmacology Research Lab
Fingerprint
Dive into the research topics where Gwo-Jyh Chang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Atrial-Selective Antiarrhythmic Efficacy and Electrophsiological Mechanisms of an Androstane Derivative with Positive Inotropic Activity
Chang, G.-J. (PI) & Yeh, Y.-H. (CoPI)
01/08/24 → 31/07/25
Project: National Science and Technology Council › National Science and Technology Council Academic Grants
-
Differential Antiarrhythmic Effect and Electrophsiological Mechanisms of an Analogue of Istaroxime Metabolite in Healthy and Cardiac Hypertrophic Guinea Pigs
Chang, G.-J. (PI) & Chen, W.-J. (CoPI)
01/08/23 → 31/07/24
Project: National Science and Technology Council › National Science and Technology Council Academic Grants
-
The Role of Aryl Hydrocarbon Receptor in the Pathogenesis of Atrial Remodeling and Fibrillation( II )
Chen, W.-J. (PI) & Chang, G.-J. (CoPI)
01/08/23 → 31/07/24
Project: National Science and Technology Council › National Science and Technology Council Academic Grants
-
Interaction between Aldh2, Ho-1 and Ferroptosis in Atrial Fibrillation
Hsu, L.-A. (PI), Chang, G.-J. (CoPI) & Yeh, Y.-H. (CoPI)
01/08/23 → 31/07/24
Project: National Science and Technology Council › National Science and Technology Council Academic Grants
-
The Role of Aryl Hydrocarbon Receptor in the Pathogenesis of Atrial Remodeling and Fibrillation( I )
Chen, W.-J. (PI) & Chang, G.-J. (CoPI)
01/08/22 → 31/07/23
Project: National Science and Technology Council › National Science and Technology Council Academic Grants
Research output
-
Aldehyde Dehydrogenase 2 (ALDH2) Deficiency, Obesity, and Atrial Fibrillation Susceptibility: Unraveling the Connection
Hsu, L. A., Yeh, Y. H., Chang, C. J., Chen, W.-J., Tsai, H. Y. & Chang, G. J., 11 02 2024, In: International Journal of Molecular Sciences. 25, 4, 2186.Research output: Contribution to journal › Journal Article › peer-review
Open Access -
Empagliflozin Attenuates Pulmonary Arterial Remodeling Through Peroxisome Proliferator-Activated Receptor Gamma Activation
Lai, Y. J., Yeh, Y. H., Huang, Y. L., De Almeida, C., Chang, G. J., Chen, W. J. & Hsu, H. H., 13 09 2024, In: ACS Pharmacology and Translational Science. 7, 9, p. 2725-2738 14 p.Research output: Contribution to journal › Journal Article › peer-review
Open Access1 Scopus citations -
Istaroxime follow-on compounds: A new class of selective SERCA2a activators for chronic heart failure treatment
Arici, M., Hsu, S. C., Ferrandi, M., Barassi, P., Ronchi, C., Torre, E., Luraghi, A., Metallo, A., Chang, G. J., Ferrari, P., Bianchi, G., Regonesi, M. E., Airoldi, C., Peri, F., Zaza, A. & Rocchetti, M., 01 06 2024, In: Vascular Pharmacology. 155, p. 107295 1 p.Research output: Contribution to journal › Journal Editorial
-
Naringin activates semaphorin 3A to ameliorate TGF-β-induced endothelial-to-mesenchymal transition related to atrial fibrillation
Lai, Y. J., Chang, S.-H., Tung, Y. C., Chang, G. J., Almeida, C., Chen, W.-J., Yeh, Y. H. & Tsai, F. C., 05 2024, In: Journal of Cellular Physiology. 239, 5, p. e31248 e31248.Research output: Contribution to journal › Journal Article › peer-review
-
Selective SERCA2a activator as a candidate for chronic heart failure therapy
Arici, M., Hsu, S. C., Ferrandi, M., Barassi, P., Ronchi, C., Torre, E., Luraghi, A., Chang, G. J., Ferrari, P., Bianchi, G., Peri, F., Zaza, A. & Rocchetti, M., 19 01 2024, In: Journal of Translational Medicine. 22, 1, p. 77 77.Research output: Contribution to journal › Journal Article › peer-review
Open Access2 Scopus citations